Lazard Asset Management LLC Exelixis, Inc. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 119,147 shares of EXEL stock, worth $4.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119,147
Previous 57,173 108.4%
Holding current value
$4.24 Million
Previous $1.28 Million 140.73%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$21.96 - $27.6 $1.36 Million - $1.71 Million
61,974 Added 108.4%
119,147 $3.09 Million
Q2 2024

Aug 14, 2024
BUY
$20.34 - $23.73 $399,030 - $465,535
19,618 Added 52.24%
57,173 $1.28 Million
Q1 2024

May 14, 2024
BUY
$20.17 - $23.93 $159,161 - $188,831
7,891 Added 26.6%
37,555 $890,000
Q4 2023

Feb 14, 2024
BUY
$19.25 - $24.13 $92,380 - $115,799
4,799 Added 19.3%
29,664 $711,000
Q3 2023

Nov 14, 2023
BUY
$19.04 - $22.74 $121,170 - $144,717
6,364 Added 34.4%
24,865 $543,000
Q2 2023

Aug 14, 2023
BUY
$18.17 - $20.48 $34,686 - $39,096
1,909 Added 11.51%
18,501 $353,000
Q1 2023

May 15, 2023
BUY
$16.3 - $19.41 $8,329 - $9,918
511 Added 3.18%
16,592 $322,000
Q4 2022

Feb 14, 2023
SELL
$14.96 - $17.39 $9,155 - $10,642
-612 Reduced 3.67%
16,081 $257,000
Q3 2022

Nov 14, 2022
BUY
$15.68 - $22.27 $85,816 - $121,883
5,473 Added 48.78%
16,693 $261,000
Q2 2022

Aug 09, 2022
SELL
$17.44 - $23.16 $7.29 Million - $9.68 Million
-418,079 Reduced 97.39%
11,220 $233,000
Q1 2022

May 13, 2022
SELL
$17.03 - $22.67 $41.5 Million - $55.2 Million
-2,436,648 Reduced 85.02%
429,299 $9.73 Million
Q4 2021

Feb 09, 2022
BUY
$15.84 - $21.88 $1.23 Million - $1.7 Million
77,752 Added 2.79%
2,865,947 $52.4 Million
Q3 2021

Nov 15, 2021
BUY
$16.3 - $21.14 $12.2 Million - $15.8 Million
746,597 Added 36.57%
2,788,195 $58.9 Million
Q2 2021

Aug 12, 2021
SELL
$17.95 - $25.56 $509,582 - $725,622
-28,389 Reduced 1.37%
2,041,598 $37.2 Million
Q1 2021

May 14, 2021
BUY
$20.53 - $25.22 $12.4 Million - $15.3 Million
605,381 Added 41.33%
2,069,987 $46.8 Million
Q4 2020

Feb 11, 2021
BUY
$18.39 - $24.8 $5.33 Million - $7.19 Million
289,840 Added 24.67%
1,464,606 $29.4 Million
Q3 2020

Nov 13, 2020
BUY
$20.67 - $26.94 $2.06 Million - $2.68 Million
99,485 Added 9.25%
1,174,766 $28.7 Million
Q2 2020

Aug 13, 2020
BUY
$16.46 - $27.42 $12.6 Million - $21 Million
764,095 Added 245.54%
1,075,281 $25.5 Million
Q1 2020

May 14, 2020
BUY
$14.46 - $21.8 $26,953 - $40,635
1,864 Added 0.6%
311,186 $5.36 Million
Q4 2019

Feb 13, 2020
BUY
$15.15 - $18.89 $1.59 Million - $1.98 Million
104,971 Added 51.37%
309,322 $5.45 Million
Q3 2019

Nov 14, 2019
BUY
$17.68 - $22.65 $893,211 - $1.14 Million
50,521 Added 32.84%
204,351 $3.61 Million
Q2 2019

Aug 14, 2019
SELL
$18.93 - $24.75 $340,929 - $445,747
-18,010 Reduced 10.48%
153,830 $3.29 Million
Q1 2019

May 13, 2019
SELL
$19.6 - $24.76 $1.01 Million - $1.28 Million
-51,595 Reduced 23.09%
171,840 $4.09 Million
Q4 2018

Feb 13, 2019
SELL
$13.65 - $21.8 $306,852 - $490,064
-22,480 Reduced 9.14%
223,435 $4.39 Million
Q3 2018

Nov 13, 2018
BUY
$15.87 - $22.4 $218,926 - $309,008
13,795 Added 5.94%
245,915 $4.36 Million
Q2 2018

Aug 13, 2018
SELL
$18.56 - $22.45 $1.7 Million - $2.06 Million
-91,567 Reduced 28.29%
232,120 $5 Million
Q2 2016

Jul 29, 2019
SELL
N/A
-2,342,162 Reduced 87.86%
323,687 $2.53 Million
Q1 2016

Jul 25, 2019
BUY
N/A
1,492,107 Added 127.12%
2,665,849 $10.7 Million
Q4 2015

Jul 24, 2019
BUY
N/A
754,940 Added 180.26%
1,173,742 $6.62 Million
Q3 2015

Jul 15, 2019
SELL
N/A
-1,097,597 Reduced 72.38%
418,802 $2.35 Million
Q2 2015

Jul 08, 2019
BUY
N/A
1,224,705 Added 419.86%
1,516,399 $5.7 Million
Q4 2014

Aug 29, 2019
BUY
N/A
291,694
291,694 $420,000

Others Institutions Holding EXEL

# of Institutions
501
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email